Legions of nanorobots target cancerous tumours with precision - Administering anti-cancer drugs redefined - Biotechnology Focus
MONTRÉAL, QC – Researchers from Polytechnique Montréal, Université de Montréal and McGill University have just achieved a spectacular breakthrough in cancer research. They have developed new nanorobotic agents capable of navigating through the bloodstream to administer a drug with precision by specifically targeting the active cancerous cells of tumours. This way of injecting medication ensures [&hellip
Join in on the conversation with Andrew Haller when you subscribe to Toronto Health.